Join the Sinusitis group to help and get support from people like you.
Sinusitis News
Related terms: Acute Sinusitis, Chronic Sinusitis, Infection, sinus, Sinus Infection, Sinusitis, Acute, Sinusitis, Chronic
Guidelines Issued for Surgical Management of Chronic Rhinosinusitis in Adults
MONDAY, June 2, 2025 – In a new clinical practice guideline issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and published online May 27 in Otolaryngology-Head and...
Nasal Endoscopic Surgery Beneficial for Chronic Sinusitis, Nasal Polyps
TUESDAY, May 6, 2025 – For patients with chronic sinusitis and nasal polyps, nasal endoscopic surgery can remove polyps in a shorter time, with less intraoperative blood loss compared with...
Sleepy Nurses Vulnerable To Common Cold, Other Infectious Diseases
MONDAY, March 10, 2025 – Sleep-deprived night shift nurses are at greater risk for the common cold and other infectious diseases, a new study says. Shift work and its impact on quality sleep can...
Bidirectional Link Seen for Psychiatric Disorders With Chronic Rhinosinusitis
MONDAY, Sept. 16, 2024 – There is a bidirectional association for anxiety and depression with chronic rhinosinusitis (CRS), according to a study published online Sept. 12 in JAMA Otolaryngology-Head...
Nasal Sprays, Behavioral Intervention Aid in Treatment of Respiratory Illness
TUESDAY, July 30, 2024 – Use of nasal sprays and a behavioral intervention promoting physical activity and stress management can reduce antibiotic use for respiratory illness, according to a study...
Current Asthma at Age 7 Linked to Chronic Rhinosinusitis in Middle Age
TUESDAY, July 16, 2024 – Current asthma, head colds, and tonsillitis at age 7 years are associated with chronic rhinosinusitis (CRS) at midlife, according to a study published online July 10 in...
FDA Approves Dupixent (dupilumab) for Chronic Rhinosinusitis with Nasal Polyposis
PARIS and TARRYTOWN, N.Y., June 26, 2019 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) for use with other medicines to treat chronic rhinosinusitis...
Intersect ENT Announces FDA Approval of Sinuva (mometasone furoate) Sinus Implant, a New In-Office Treatment Option for Recurrent Nasal Polyps
MENLO PARK, Calif.--(BUSINESS WIRE)--Dec. 11, 2017-- Intersect ENT, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced...
FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs for Systemic Use: Drug Safety Communication - Warnings Updated Due to Disabling Side Effects
ISSUE: FDA approved changes to the labels of fluoroquinolone antibacterial drugs for systemic use (i.e., taken by mouth or by injection). Includes the following currently available fluoroquinolones:...
FDA Medwatch Alert: Fluoroquinolone Antibacterial Drugs: Drug Safety Communication - FDA Advises Restricting Use for Certain Uncomplicated Infections
ISSUE: FDA is advising that the serious side effects associated with fluoroquinolone antibacterial drugs generally outweigh the benefits for patients with sinusitis, bronchitis, and uncomplicated...
Further information
Related condition support groups
Upper Respiratory Tract Infection
Related drug support groups
prednisone, amoxicillin, clindamycin, azithromycin, Bactrim, Cipro, ciprofloxacin, Zithromax, Augmentin, view more... Levaquin, levofloxacin, clarithromycin, amoxicillin / clavulanate, cefdinir, sulfamethoxazole / trimethoprim, Bactrim DS